Literature DB >> 33547502

Chronic active Epstein-Barr virus infection of T cell type presenting with hemophagocytic lymphohistiocytosis in a Caucasian adult.

Debbie Jiang1, Zhao Ming Dong2,3, Nicholas Burwick4,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33547502     DOI: 10.1007/s00277-021-04435-w

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

Authors:  J I Henter; M Aricò; R M Egeler; G Elinder; B E Favara; A H Filipovich; H Gadner; S Imashuku; G Janka-Schaub; D Komp; S Ladisch; D Webb
Journal:  Med Pediatr Oncol       Date:  1997-05

Review 2.  How I treat hemophagocytic lymphohistiocytosis in the adult patient.

Authors:  Alison M Schram; Nancy Berliner
Journal:  Blood       Date:  2015-03-10       Impact factor: 22.113

3.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

4.  Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Zaher K Otrock; Charles S Eby
Journal:  Am J Hematol       Date:  2015-01-16       Impact factor: 10.047

5.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Takaharu Suzuki; Yasuji Kozai; Koji Kato; Masaharu Miyahara; Toshiaki Yujiri; Ilseung Choi; Katsumichi Fujimaki; Tsuyoshi Muta; Masaaki Kume; Sayaka Moriguchi; Shinobu Tamura; Takeharu Kato; Hiroyuki Tagawa; Junya Makiyama; Yuji Kanisawa; Yuya Sasaki; Daisuke Kurita; Kyohei Yamada; Joji Shimono; Hirohito Sone; Jun Takizawa; Masao Seto; Hiroshi Kimura; Koichi Ohshima
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.